Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms].
Hilbe W, Aigner K, Dittrich C, Eckmayr J, Fiegl M, Flicker M, Forstner B, Greil R, Jamnig H, Krajnik G, Lang A, Mohn-Staudner A, Schinko H, Studnicka M, Pirker R, Ploner F, Rothmund J, Schiller L, Zabernigg A, Zöchbauer-Müller S. Hilbe W, et al. Among authors: krajnik g. Wien Klin Wochenschr. 2007;119(7-8):259-66. doi: 10.1007/s00508-007-0792-5. Wien Klin Wochenschr. 2007. PMID: 17492355 Review. German. No abstract available.
Phase II trial of gemcitabine in advanced non-small-cell lung cancer.
Malayeri R, Ulsperger E, Baumgartner G, Forstner B, Aigner K, Hubner M, Kummer F, Krajnik G, Zöchbauer S, Krejcy K, Huber H, Pirker R. Malayeri R, et al. Among authors: krajnik g. Wien Klin Wochenschr. 1997 Sep 19;109(17):688-91. Wien Klin Wochenschr. 1997. PMID: 9331958 Clinical Trial.
Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC).
Pirker R, Krajnik G, Zöchbauer S, Malayeri R, Kneussl M, Huber H. Pirker R, et al. Among authors: krajnik g. Ann Oncol. 1995 Oct;6(8):833-5. doi: 10.1093/oxfordjournals.annonc.a059324. Ann Oncol. 1995. PMID: 8589023 Free article. Clinical Trial.
Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer.
Pohl G, Krajnik G, Malayeri R, Müller RM, Klepetko W, Eckersberger F, Schäfer-Prokop C, Pokrajac B, Schmeikal S, Maier A, Ambrosch G, Woltsche M, Minar W, Pirker R. Pohl G, et al. Among authors: krajnik g. Lung Cancer. 2006 Oct;54(1):63-7. doi: 10.1016/j.lungcan.2006.05.027. Epub 2006 Aug 22. Lung Cancer. 2006. PMID: 16926060 Clinical Trial.
15 results